What is the long-term trend for Halozyme Therapeutics's contract liabilities and refund liability?

Over 3 years (2022 to 2025), Halozyme Therapeutics's contract liabilities and refund liability has grown at a 15.5% compound annual growth rate (CAGR), from $30.26M to $46.59M.

Halozyme Therapeutics HALO Contract Liabilities and Refund Liability

Contract Liabilities and Refund Liability at other companies

OGE EnergyOGE

$55.3M+3,587%

ExelixisEXEL

$65.89M+13.9%

LKQLKQ

$126M+0.8%

Texas Pacific LandTPL

$18.97M-6.6%

Generac HoldingsGNRC

$236.5M+18.2%

Service Corporation InternationalSCI

$34.25M-3.1%

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Gross profit$297.5M+37.4%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerRefundLiability.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's contract liabilities and refund liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's contract liabilities and refund liability?: Halozyme Therapeutics (HALO) reported contract liabilities and refund liability of $44.55M in Q1 2026.
How has Halozyme Therapeutics's contract liabilities and refund liability changed year-over-year?: Halozyme Therapeutics's contract liabilities and refund liability decreased by 15.9% year-over-year, from $52.94M to $44.55M.
What is the long-term trend for Halozyme Therapeutics's contract liabilities and refund liability?: Over 3 years (2022 to 2025), Halozyme Therapeutics's contract liabilities and refund liability has grown at a 15.5% compound annual growth rate (CAGR), from $30.26M to $46.59M.